POAI NASDAQ
Predictive Oncology Inc.
1W: -29.7%
1M: +33.0%
3M: +101.7%
YTD: -34.0%
1Y: -70.8%
3Y: -91.9%
5Y: -98.4%
$4.91
Last traded 2026-05-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships0
As Filer
counterparties named
6
As Counterparty
mentioned by others
2021-12-01
Earliest Filing
2025-07-08
Latest Filing
Mentioned As Counterparty
6 mentionsOther companies that named POAI in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| AGPU Predictive Oncology Inc. | acquirer | Company issuing shares to the Investor | 2025-07-08 | View |
| AGPU Predictive Oncology Inc. | acquirer | Seller of assets related to automated medical fluid disposal business | 2025-03-20 | View |
| LNAI RENOVARO INC. | acquirer | Target of Renovaro's proposed acquisition; extension agreement signed to amend LOI and acquire initial shares. | 2025-03-06 | View |
| LNAI RENOVARO INC. | acquirer | Target company to be acquired by Renovaro in exchange for preferred stock. | 2025-01-07 | View |
| AGPU Predictive Oncology Inc. | acquirer | Target company in proposed acquisition | 2025-01-06 | View |
| AGPU Predictive Oncology Inc. | partner | Parent company of the acquiring subsidiary | 2021-12-01 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR